Moleculin Biotech, Inc. Operating Lease, Liability, Noncurrent
Moleculin Biotech, Inc. (MBRX) had Operating Lease, Liability, Noncurrent of $147.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-13
- 2026-06-30: Operating Lease, Liability, Noncurrent $147.00K.
- 2026-03-31: Operating Lease, Liability, Noncurrent $185.00K.
- 2025-12-31: Operating Lease, Liability, Noncurrent $222.00K.
- 2025-09-30: Operating Lease, Liability, Noncurrent $258.00K.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $147.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $185.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $222.00K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $258.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $292.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $326.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $358.00K 10-K · filed 2026-03-18 |
| 2024-09-30 | $390.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $420.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $450.00K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $474.00K 10-K · filed 2025-03-21 |
| 2023-09-30 | $496.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $291.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $308.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $335.00K 10-K · filed 2024-03-22 |
| 2022-09-30 | $365.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $388.00K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $50.00K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $63.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | $75.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $94.00K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $127.00K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $159.00K 10-K · filed 2022-03-24 |
| 2020-09-30 | $190.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $220.00K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $248.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $276.00K 10-K · filed 2021-03-24 |
| 2019-09-30 | $304.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $171.00K 10-Q · filed 2019-08-16 |
| 2019-03-31 | $180.00K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |